A Study to Investigate the Safety and Efficacy of YY003 in Adults With Moderate to Severe Glabellar Lines
Clinical trial NCT06481475 · COMPLETED
Trial details
- NCT number
- NCT06481475
- Sponsor
- Chongqing Claruvis Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-09
- Primary completion
- 2025-10-22
- Enrollment
- 149
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.